Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)
Spigel, David R., McCleod, Michael, Jotte, Robert M., Einhorn, Lawrence, Horn, Leora, Waterhouse, David M., Creelan, Ben, Babu, Sunil, Leighl, Natasha B., Chandler, Jason C., Couture, Felix, Keogh, George, Goss, Glenwood, Daniel, Davey B., Garon, Edward B., Schwartzberg, Lee S., Sen, Rohini, Korytowsky, Beata, Li, Ang, Aanur, Nivedita, Hussein, Maen A.
Published in Journal of thoracic oncology (01.09.2019)
Published in Journal of thoracic oncology (01.09.2019)
Get full text
Journal Article
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153
Waterhouse, David M, Garon, Edward B, Chandler, Jason, McCleod, Michael, Hussein, Maen, Jotte, Robert, Horn, Leora, Daniel, Davey B, Keogh, George, Creelan, Ben, Einhorn, Lawrence H, Baker, Justin, Kasbari, Samer, Nikolinakos, Petros, Babu, Sunil, Couture, Felix, Leighl, Natasha B, Reynolds, Craig, Blumenschein, Jr, George, Gunuganti, Vijay, Li, Ang, Aanur, Nivedita, Spigel, David R
Published in Journal of clinical oncology (20.11.2020)
Published in Journal of clinical oncology (20.11.2020)
Get full text
Journal Article
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study
Hart, Lowell L., Ferrarotto, Renata, Andric, Zoran G., Beck, J. Thaddeus, Subramanian, Janakiraman, Radosavljevic, Davorin Z., Zaric, Bojan, Hanna, Wahid T., Aljumaily, Raid, Owonikoko, Taofeek K., Verhoeven, Didier, Xiao, Jie, Morris, Shannon R., Antal, Joyce M., Hussein, Maen A.
Published in Advances in therapy (01.01.2021)
Published in Advances in therapy (01.01.2021)
Get full text
Journal Article
Monoclonal gammopathy of thrombotic/thrombocytopenic significance
Kanack, Adam J., Schaefer, Jordan K., Sridharan, Meera, Splinter, Noah P., Kohlhagen, Mindy C., Singh, Bandana, De Lorenzo, Silvana B., Mauch, Emily E., Hussein, Maen A., Shaikh, Marwan, Kumar, Shaji, Wen, Renren, Wang, Demin, Murray, David, Padmanabhan, Anand
Published in Blood (06.04.2023)
Published in Blood (06.04.2023)
Get full text
Journal Article
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer
Yu, Hui, Batenchuk, Cory, Badzio, Andrzej, Boyle, Theresa A., Czapiewski, Piotr, Chan, Daniel C., Lu, Xian, Gao, Dexiang, Ellison, Kim, Kowalewski, Ashley A., Rivard, Christopher J., Dziadziuszko, Rafal, Zhou, Caicun, Hussein, Maen, Richards, Donald, Wilks, Sharon, Monte, Marc, Edenfield, William, Goldschmidt, Jerome, Page, Ray, Ulrich, Brian, Waterhouse, David, Close, Sandra, Jassem, Jacek, Kulig, Kimary, Hirsch, Fred R.
Published in Journal of thoracic oncology (01.01.2017)
Published in Journal of thoracic oncology (01.01.2017)
Get full text
Journal Article
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study
Tokito, Takaaki, Kolesnik, Oleksii, Sørensen, Jens, Artac, Mehmet, Quintela, Martín Lázaro, Lee, Jong-Seok, Hussein, Maen, Pless, Miklos, Paz-Ares, Luis, Leopold, Lance, Daniel, Jeannie, Munteanu, Mihaela, Samkari, Ayman, Xu, Lu, Butts, Charles
Published in BMC cancer (25.07.2024)
Published in BMC cancer (25.07.2024)
Get full text
Journal Article
IMpower131: Primary PFS and safety analysis of a randomized phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel as 1L therapy in advanced squamous NSCLC
Jotte, Robert M., Cappuzzo, Federico, Vynnychenko, Ihor, Stroyakovskiy, Daniil, Rodriguez Abreu, Delvys, Hussein, Maen A., Soo, Ross A., Conter, Henry Jacob, Kozuki, Toshiyuki, Silva, Carlos, Graupner, Vilma, Sun, Shawn, Lin, Ray S, Kelsch, Claudia, Kowanetz, Marcin, Hoang, Tien, Sandler, Alan, Socinski, Mark A.
Published in Journal of clinical oncology (20.06.2018)
Published in Journal of clinical oncology (20.06.2018)
Get full text
Journal Article
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
West, Howard, McCleod, Michael, Hussein, Maen, Morabito, Alessandro, Rittmeyer, Achim, Conter, Henry J, Kopp, Hans-Georg, Daniel, Davey, McCune, Steven, Mekhail, Tarek, Zer, Alona, Reinmuth, Niels, Sadiq, Ahad, Sandler, Alan, Lin, Wei, Ochi Lohmann, Tania, Archer, Venice, Wang, Lijia, Kowanetz, Marcin, Cappuzzo, Federico
Published in The lancet oncology (01.07.2019)
Published in The lancet oncology (01.07.2019)
Get full text
Journal Article
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
Jotte, Robert, Cappuzzo, Federico, Vynnychenko, Ihor, Stroyakovskiy, Daniil, Rodríguez-Abreu, Delvys, Hussein, Maen, Soo, Ross, Conter, Henry J., Kozuki, Toshiyuki, Huang, Kuan-Chieh, Graupner, Vilma, Sun, Shawn W., Hoang, Tien, Jessop, Helen, McCleland, Mark, Ballinger, Marcus, Sandler, Alan, Socinski, Mark A.
Published in Journal of thoracic oncology (01.08.2020)
Published in Journal of thoracic oncology (01.08.2020)
Get full text
Journal Article
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study
Johnson, Melissa L, Cho, Byoung Chul, Luft, Alexander, Alatorre-Alexander, Jorge, Geater, Sarayut Lucien, Laktionov, Konstantin, Kim, Sang-We, Ursol, Grygorii, Hussein, Maen, Lim, Farah Louise, Yang, Cheng-Ta, Araujo, Luiz Henrique, Saito, Haruhiro, Reinmuth, Niels, Shi, Xiaojin, Poole, Lynne, Peters, Solange, Garon, Edward B, Mok, Tony
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
Cho, Byoung Chul, Abreu, Delvys Rodriguez, Hussein, Maen, Cobo, Manuel, Patel, Anjan J, Secen, Nevena, Lee, Ki Hyeong, Massuti, Bartomeu, Hiret, Sandrine, Yang, James Chih Hsin, Barlesi, Fabrice, Lee, Dae Ho, Ares, Luis Paz, Hsieh, Robert W, Patil, Namrata S, Twomey, Patrick, Yang, Xiaoying, Meng, Raymond, Johnson, Melissa L
Published in The lancet oncology (01.06.2022)
Published in The lancet oncology (01.06.2022)
Get full text
Journal Article
MyTACTIC: Afficacy and safety of atezolizumab (atezo) + chemotherapy (chemo) in patients (pts) with advanced unresectable/metastatic solid tumors with high tumor mutational burden (TMB-H) or high microsatellite instability (MSI-H)/deficient mismatch repair (dMMR)
Spigel, David R., Hussein, Maen A., Zuniga, Richard, Mahadevan, Daruka, Winn, Robert, Darbonne, Walter C., Yoo, Bongin, Kim, Young, Whitehead, Zach, Vanderwalde, Ari M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in combination with BI 836880, a VEGF/Ang2-blocking nanobody, in patients (pts) with advanced colorectal cancer (CRC)
Ulahannan, Susanna Varkey, Percent, Ivor John, Arrowsmith, Edward, Hussein, Maen A., Bhanderi, Viralkumar K., Hamm, John, Durm, Greg Andrew, Erzen, Damijan, Mohanty, Prasant, Spigel, David R.
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Real-world practice patterns and barriers to quality care in acute myeloid leukemia (AML)
Hussein, Maen A., Patel, Taral, Ellipeddi, Pavani, Farris, Breanne, Crawford, Rebecca R, Carter, Jeffrey D., Sapir, Tamar, Wang, Eunice S.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I) (1300)
Lee, Elizabeth, Rodon, Jordi, Demeure, Michael, Deming, Dustin, Federman, Noah, McKean, Meredith, Spira, Alexander, Kwiatkowski, David, Hussein, Maen, Gordon, Erlinda, Crockett, David, Ganjoo, Kristen, Schulte, Brian, Cranmer, Lee, Schmid, Anita, Navarro, Willis, Itri, Loretta, Iyer, Gopa
Published in Gynecologic oncology (01.09.2023)
Published in Gynecologic oncology (01.09.2023)
Get full text
Journal Article
Practice transformation at scale through a microsystems quality improvement (QI) approach
Gordan, Lucio N., Chaudhry, Basit Iqbal, Hussein, Maen A., Connor, Nora, Yue, Andrew, Diaz, Michael, Strickland, T. R., Tran, Lisa, Walcker, Nathan
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Platform trial of BI 754091, an anti-PD-1 antibody, in patients with previously treated advanced solid tumors: Combination with BI 836880, a VEGF/Ang2-blocking nanobody
Hussein, Maen A., Bendell, Johanna C., Arkenau, Hendrik-Tobias, Chu, Quincy S., Hansen, Aaron Richard, Erzen, Damijan, Sun, Zhichao, Lucarelli, Anthony, Percent, Ivor John
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Real-world practice patterns in follicular lymphoma (FL) care at community oncology centers
Barr, Paul M., Patel, Taral, Dela Cruz, Servillano E., Hussein, Maen A., Castine, Michael J., Farris, Breanne Y, Crawford, Rebecca R, Carter, Jeffrey D., Sapir, Tamar
Published in Journal of clinical oncology (10.10.2020)
Published in Journal of clinical oncology (10.10.2020)
Get full text
Journal Article
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON)
Garon, Edward B, Cho, Byoung Chul, Luft, Alexander, Alatorre-Alexander, Jorge, Geater, Sarayut Lucien, Kim, Sang-We, Ursol, Grygorii, Hussein, Maen, Lim, Farah Louise, Yang, Cheng-Ta, Araujo, Luiz Henrique, Saito, Haruhiro, Reinmuth, Niels, Medic, Nenad, Mann, Helen, Shi, Xiaojin, Peters, Solange, Mok, Tony, Johnson, Melissa
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2023)
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2023)
Get full text
Journal Article